- Home
- NDLS vs ENZ Comparison
NDLS vs ENZ Comparison
Compare NDLS & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NDLS
- ENZ
- Stock Information
- Founded
- NDLS 1995
- ENZ 1976
- Country
- NDLS United States
- ENZ United States
- Employees
- NDLS N/A
- ENZ N/A
- Industry
- NDLS Restaurants
- ENZ Medical Specialities
- Sector
- NDLS Consumer Discretionary
- ENZ Health Care
- Exchange
- NDLS Nasdaq
- ENZ Nasdaq
- Market Cap
- NDLS 54.8M
- ENZ 59.7M
- IPO Year
- NDLS 2013
- ENZ N/A
- Fundamental
- Price
- NDLS $0.83
- ENZ $1.03
- Analyst Decision
- NDLS Strong Buy
- ENZ
- Analyst Count
- NDLS 2
- ENZ 0
- Target Price
- NDLS $3.00
- ENZ N/A
- AVG Volume (30 Days)
- NDLS 253.5K
- ENZ 122.4K
- Earning Date
- NDLS 11-06-2024
- ENZ 12-13-2024
- Dividend Yield
- NDLS N/A
- ENZ 9.62%
- EPS Growth
- NDLS N/A
- ENZ N/A
- EPS
- NDLS N/A
- ENZ N/A
- Revenue
- NDLS $495,817,000.00
- ENZ $31,907,000.00
- Revenue This Year
- NDLS $0.11
- ENZ N/A
- Revenue Next Year
- NDLS $0.39
- ENZ N/A
- P/E Ratio
- NDLS N/A
- ENZ N/A
- Revenue Growth
- NDLS N/A
- ENZ 2.72
- 52 Week Low
- NDLS $0.80
- ENZ $0.99
- 52 Week High
- NDLS $3.50
- ENZ $1.50
- Technical
- Relative Strength Index (RSI)
- NDLS 27.15
- ENZ 30.02
- Support Level
- NDLS $0.81
- ENZ $1.09
- Resistance Level
- NDLS $1.04
- ENZ $1.18
- Average True Range (ATR)
- NDLS 0.08
- ENZ 0.04
- MACD
- NDLS -0.03
- ENZ -0.01
- Stochastic Oscillator
- NDLS 6.09
- ENZ 5.88
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. It focuses on delivering and applying its technology to produce products and services to allow its customers to meet their clinical needs. The company has Enzo clinical labs, Enzo life sciences, Enzo therapeutics operating segments. It derives the majority of its revenues from the Clinical lab's segment.